v3.25.4
Supplementary Cash Flow Information (Tables)
12 Months Ended
Dec. 31, 2025
Supplementary Cash Flow Information  
Schedule of supplemental balance sheet disclosures

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2025

​

​

Unrestricted cash and cash

​

​

​

​

​

​

​

​

​

​

​

 

​

​

equivalents included in the

​

​

​

​

​

​

​

Cash and cash equivalents included on

​

​

consolidated statement of cash flows

​

Restricted cash and cash equivalents

​

the consolidated balance sheet

​

  ​ ​ ​

​

  ​ ​ ​

Cash

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Cash

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Cash

  ​ ​ ​

​

​

​

Cash

 

equivalents

​

Total

​

Cash

 

equivalents

​

Total

​

Cash

 

equivalents

​

Total

Holding company cash and investments

 

89.1

 

108.1

 

197.2

 

—

 

—

 

—

 

89.1

 

108.1

 

197.2

Subsidiary cash and short term investments

 

2,265.1

 

3,658.2

 

5,923.3

 

344.6

 

295.8

 

640.4

 

2,609.7

 

3,954.0

 

6,563.7

Fairfax India

 

17.4

 

0.4

 

17.8

 

—

 

4.2

 

4.2

 

17.4

 

4.6

 

22.0

Assets held for sale (note 21)

​

9.4

​

95.1

​

104.5

​

0.1

​

—

​

0.1

​

9.5

​

95.1

​

104.6

​

 

2,381.0

 

3,861.8

 

6,242.8

 

344.7

 

300.0

 

644.7

 

2,725.7

 

4,161.8

 

6,887.5

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2024

​

​

Unrestricted cash and cash 

​

​

​

​

​

​

​

​

​

​

​

 

​

​

equivalents  included in the 

​

​

​

​

​

​

​

Cash and cash equivalents included on 

​

​

consolidated statement  of cash flows

​

Restricted cash and cash equivalents

​

the consolidated balance sheet

​

  ​ ​ ​

​

  ​ ​ ​

Cash

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Cash

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Cash

  ​ ​ ​

​

​

​

Cash

​

equivalents

​

Total

​

Cash

​

equivalents

​

Total

​

Cash

​

equivalents

​

Total

Holding company cash and investments

 

146.2

 

362.0

 

508.2

 

155.0

 

—

 

155.0

 

301.2

 

362.0

 

663.2

Holding company assets pledged for derivative obligations

 

—

 

101.1

 

101.1

 

—

 

—

 

—

 

—

 

101.1

 

101.1

Subsidiary cash and short term investments

 

2,411.2

 

3,010.2

 

5,421.4

 

1,000.1

 

240.6

 

1,240.7

 

3,411.3

 

3,250.8

 

6,662.1

Fairfax India

 

55.1

 

26.7

 

81.8

 

—

 

4.4

 

4.4

 

55.1

 

31.1

 

86.2

​

 

2,612.5

 

3,500.0

 

6,112.5

 

1,155.1

 

245.0

 

1,400.1

 

3,767.6

 

3,745.0

 

7,512.6

​

Schedule of cash flow, supplemental disclosures

Details of certain cash flows included in the consolidated statement of cash flows for the years ended December 31 were as follows:

​

​

​

​

​

​

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Net (purchases) sales of investments classified at FVTPL

 

  ​

 

  ​

Short term investments

 

(1,268.6)

 

1,267.0

Bonds

 

(2,589.6)

 

(1,888.1)

Preferred stocks

 

(9.1)

 

(11.3)

Common stocks

 

(169.6)

 

(248.5)

Net derivatives and other invested assets

 

(22.2)

 

365.1

​

 

(4,059.1)

 

(515.8)

​

​

​

​

​

Changes in operating assets and liabilities

 

​

 

​

Net (increase) decrease in restricted cash and cash equivalents

 

746.5

 

(733.3)

Insurance contract receivables

​

(231.0)

​

144.2

Reinsurance contract assets held

​

(377.2)

​

17.2

Insurance contract payables

 

61.3

 

(273.8)

Insurance contract liabilities

​

4,329.4

​

2,388.4

Other receivables

 

62.9

 

(36.9)

Accounts payable and accrued liabilities

 

47.4

 

312.5

Other

 

(380.9)

 

(411.5)

​

 

4,258.4

 

1,406.8

​

​

​

​

​

Net interest and dividends received

 

​

 

​

Interest and dividends received

 

2,584.2

 

2,570.6

Interest paid on borrowings

 

(677.4)

 

(508.8)

Interest paid on lease liabilities

 

(73.0)

 

(57.3)

​

 

1,833.8

 

2,004.5

​

​

​

​

​

​

​

​

​

​

Net income taxes paid

 

(953.5)

 

(1,005.6)

​